SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12B-25
                                                  Commission File Number 1-11765
                                                        CUSIP Number 58501K 10 7

                           NOTIFICATION OF LATE FILING

(Check One):      |X|  Form  10-K,  10-KSB  |_| Form  20-F  |_| Form  11-K
                  |_|  Form 10-Q, 10-QSB    |_| Form N-SAR

      For Period Ended:      DECEMBER 31, 2003
                       ---------------------------------------------------------

|_| Transition Report on Form 10-K          |_| Transition Report on Form 10-Q
|_| Transition Report on Form 20-F          |_| Transition  Report on Form N-SAR
|_| Transition Report on Form 11-K
      For the Transition Period Ended:
                                      ------------------------------------------

READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM.  PLEASE PRINT OR TYPE.

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:    N/A
                                               --------

                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant MEDJET INC.
                       ---------------------------------------------------------

Former name if applicable
     N/A
- ---------------------------------

Address of Principal Executive Office (STREET AND NUMBER)
     1090 KING GEORGES POST ROAD, SUITE 301
- --------------------------------------------------------------------------------
City, State and Zip Code EDISON, NEW JERSEY 08837
                         -------------------------------------------------------

                                     PART II
                             RULE 12B-25 (B) AND (C)

      If the subject  report could not be filed without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed.
(Check box if appropriate)

|X|  (a) The reasons  described  in  reasonable  detail in Part III of this form
     could not be eliminated without unreasonable effort or expense;

|X|  (b) The subject annual report,  semi-annual  report,  transition  report on
     Form 10-K,  Form 20-F,  Form 11-K or Form N-SAR, or portion thereof will be
     filed on or before the 15th calendar day following the prescribed due date;
     or the  subject  quarterly  report or  transition  report on Form 10-Q,  or
     portion thereof will be filed on or before the fifth calendar day following
     the prescribed due date; and

|_|  (c) The accountant's  statement or other exhibit required by Rule 12b-25(c)
     has been attached if applicable.


                                       1



                                    PART III
                                    NARRATIVE

      State below in  reasonable  detail the  reasons why Form 10-K,  Form 20-F,
Form 11-K, Form 10-Q, Form N-SAR or the transition  report portion thereof could
not be filed within the prescribed time period.

      Medjet Inc. (the  "Company") had no revenues  during fiscal year 2003, and
its research and  development  activities  have been  discontinued  as of August
2003. The Company is currently pursuing outside funding options which will allow
the Company to continue as a going concern,  and the Company requires additional
time to assemble and evaluate  information  regarding such funding for potential
disclosure in its Form 10-KSB.

      Due to the above matters,  timely filing of the Company's Annual Report on
Form 10-KSB for the period  ended  December  31, 2003 could not be  accomplished
without unreasonable effort and expense.  Accordingly,  the Company respectfully
requests an extension  of the filing date of such Form 10-KSB.  The Company will
file such Form 10-KSB as soon as practicable  after the date hereof,  but in any
event on or before the fifteenth calendar day following the prescribed due date.


                                     PART IV
                                OTHER INFORMATION

      (1) Name and  telephone  number  of person  to  contact  in regard to this
notification.

            EUGENE I. GORDON                    (732) 738-3990
- --------------------------------------------------------------------------------
               (Name)                           (Area Code) + (Telephone Number)

      (2) Have all other periodic  reports required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940  during the  preceding  12 months or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).
                                                               |X| Yes  |_| No

      (3) Is it anticipated that any significant change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
                                                               |X| Yes  |_| No
      If so: attach an explanation of the anticipated  change,  both narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

      The Company has had no revenue  during  fiscal year 2003 and the Company's
earnings  statements to be attached to its Form 10-KSB will reflect such lack of
revenue.

                                   Medjet Inc.
- --------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

      Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date:  MARCH 30, 2004                        By: /s/ Eugene I. Gordon
       ------------------                       --------------------------------
                                                   Eugene I. Gordon,
                                                   Chief Executive Officer


                                       2